Contribution of oxidative stress to radiosensitization by a combination of 2-DG and 6-AN in human cancer cell line.

In the present studies, the role of oxidative stress in radiosensitization by a combination of 2-DG and 6-aminonicotinamide (6-AN) was examined in a human glioma cell line (BMG-1: wild type p53). Presence of 2-DG or 6-AN for 4 hr after irradiation (gamma ray 2.5 Gy) significantly enhanced the radiation-induced cell death by 18% and the combination (2-DG + 6-AN) enhanced the cell death by 35%. Neither 2-DG nor 6-AN had any further significant effect on the glutathione levels in irradiated cells. However, the combination (2-DG + 6-AN) caused a significant decrease in GSH content, increase in GSSG levels, and enhanced the superoxide radical generation under these conditions. The enhanced cell death caused by the combination (2-DG + 6-AN) mainly resulted by the process of apoptosis as revealed by annexin V binding and was associated with elevated levels of Cyclin B1. However, no significant change was observed in the levels of Bcl-2. Thus, for the first time, our results have demonstrated that the radiosensitizing effects of these modifiers could also be mediated through alterations in the oxidative stress besides energy limited inhibition of repair and recovery processes.
AuthorsR Varshney, J S Adhikari, B S Dwarakanath
JournalIndian journal of experimental biology (Indian J Exp Biol) Vol. 41 Issue 12 Pg. 1384-91 (Dec 2003) ISSN: 0019-5189 [Print] India
PMID15320490 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Radiation-Sensitizing Agents
  • 6-Aminonicotinamide
  • Deoxyglucose
  • 6-Aminonicotinamide (administration & dosage, pharmacology)
  • Cell Line, Tumor
  • Deoxyglucose (administration & dosage, pharmacology)
  • Humans
  • Oxidative Stress
  • Radiation-Sensitizing Agents (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: